Viewing Study NCT00715793

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2026-01-05 @ 5:19 PM
Study NCT ID: NCT00715793
Status: COMPLETED
Last Update Posted: 2017-10-03
First Post: 2008-06-27
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma
Sponsor: Hussein Tawbi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Decitabine View
None Temozolomide View
None Metastatic View
None Melanoma View
None Non-resectable View
None Stage IIIB melanoma View
None stage IV melanoma View
None TMZ View
None DTIC View
None promoter methylation View
None skin cancer View
None chemotherapy View